Current HIV screening guidelines are too conservative

March 13, 2013

Early HIV treatment can save lives as well as have profound prevention benefits. But those infected with the virus first must be identified before they can be helped.

In a new study, two Northwestern University researchers report that current (CDC) HIV are too conservative and that more frequent testing would be cost-effective in the long run for both high- and low-risk groups.

The Northwestern team performed a mathematical modeling study to assess "optimal testing frequencies" for in different risk groups. They concluded screening should be done up to every three months for the highest-risk individuals and low-risk groups should be tested every three years.

The CDC currently recommends annual testing for high-risk groups, such as people with HIV-positive sexual partners, people with multiple sexual partners, and sex workers, and once-in-a-lifetime testing for low-risk groups (whose annual risk of acquiring HIV is only one-hundredth of one percent).

"Our results should encourage policymakers and medical professionals to reconsider how often adolescents and adults should be tested for HIV," said Benjamin Armbruster, an assistant professor of industrial engineering and management sciences at Northwestern's McCormick School of Engineering and Applied Science.

He and Aaron Lucas, a doctoral student in Armbruster's group, modeled various scenarios in an attempt to "optimize the tradeoff" between the societal costs of testing versus the benefits of earlier HIV diagnosis over a patient's lifetime.

Their study is published in the March 2013 issue of AIDS, the official journal of the International AIDS Society.

Frequent testing has been shown to be an effective method for identifying new HIV infections. In the past, people with new HIV infections weren't treated until they had significant declines in immune functioning, as measured by the . But there is a growing consensus that antiretroviral treatment is beneficial for all HIV-infected patients, regardless of CD4 count. Starting treatment immediately after diagnosis also reduces the risk of transmitting HIV.

Within its limitations, the Northwestern study suggests that current recommendations for HIV testing are "too conservative, especially for low-risk groups who would benefit from more frequent testing."

Explore further: AIDS journal publishes findings of two important studies

More information: The article, titled "The cost-effectiveness of expanded HIV screening in the United States," is available at bit.ly/13PYGDc

Related Stories

AIDS journal publishes findings of two important studies

March 4, 2013
The results of two important studies have been published in the March issue of AIDS, the official journal of the International AIDS Society. One study notes that screening for HIV should be performed more frequently—up ...

Wednesday is national HIV testing day

June 26, 2012
(HealthDay) -- More than 1 million people in the United States are living with HIV, the virus that causes AIDS, but 20 percent of them don't know they're infected.

Canada should adopt routine HIV testing

November 26, 2012
Offering routine HIV testing to the general population rather than only to high-risk individuals will significantly reduce illness and death, argues Dr. Julio Montaner and coauthors in an editorial in CMAJ (Canadian Medical ...

New push for most in US to get at least one HIV test

November 19, 2012
There's a new push to make testing for the AIDS virus as common as cholesterol checks.

Many Americans with HIV go untreated: study

November 29, 2011
Nearly three quarters of the 1.2 million Americans with HIV do not have their infection under control, raising the risk of death from AIDS and transmission to others, said a US study on Tuesday.

Recommended for you

Girl's HIV infection seems under control without AIDS drugs

July 24, 2017
A South African girl born with the AIDS virus has kept her infection suppressed for more than eight years after stopping anti-HIV medicines—more evidence that early treatment can occasionally cause a long remission that, ...

Meds by monthly injection might revolutionize HIV care (Update)

July 24, 2017
Getting a shot of medication to control HIV every month or two instead of having to take pills every day could transform the way the virus is kept at bay.

Candidate AIDS vaccine passes early test

July 24, 2017
The three-decade-old quest for an AIDS vaccine received a shot of hope Monday when developers announced that a prototype triggered the immune system in an early phase of human trials.

Paris spotlight on latest in AIDS science

July 21, 2017
Some 6,000 HIV experts gather in Paris from Sunday to report advances in AIDS science as fading hopes of finding a cure push research into new fields.

Scientists elicit broadly neutralizing antibodies to HIV in calves

July 20, 2017
Scientists supported by the National Institutes of Health have achieved a significant step forward, eliciting broadly neutralizing antibodies (bNAbs) to HIV by immunizing calves. The findings offer insights for HIV vaccine ...

Heart toxin reveals new insights into HIV-1 integration in T cell genome

July 20, 2017
Human immunodeficiency virus (HIV)-1 may have evolved to integrate its genetic material into certain immune-cell-activating genes in humans, according to new research published in PLOS Pathogens.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.